OpGen Inc. (OPGN)
OTC
Closed
Oct 9, 2026
Day's Range
3.8552 wk Range
0.000100Overview - OPGN - OpGen Inc.
Key Statistics
Valuation
Enterprise Value
152.54M
P/E (Trailing)
137.50
P/E (Forward)
-85.34
PEG Ratio
-1.00
Price / Sales (TTM)
27.91
Price / Book
24.52
EV / EBITDA
22.30
Profitability
Profit Margin
76.03%
Operating Margin
73.93%
Return on Assets
45.93%
Return on Equity
104.12%
Ownership
Shares Outstanding
10.07M
Float
3.15M
Short % of Shares Outstanding
1.79%
Held by Insiders
72.56%
Held by Institutions
0.00%
Price stats
Beta
-3,052.63
50-Day Avg
22.24
200-Day Avg
8.61
Dividends
Payout Ratio
0.00%
Market Cap - OPGN - OpGen Inc.
Peers - OPGN - OpGen Inc.
Peer Comparison
Compared with companies in Capital Markets listed on OTC.
Profile Summary - OPGN - OpGen Inc.
About
OpGen Inc. is a biotechnology company that focuses on developing molecular diagnostics and bioinformatics solutions aimed at combating infectious diseases. The company's core purpose is to provide innovative diagnostic products and services that enable rapid identification and treatment guidance for a variety of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
